| Joseph Hsinting Lin, DO | |
|
1600 Providence Dr, Waco, TX 76707-2261 | |
| (254) 313-4200 | |
| (254) 313-4531 |
| Full Name | Joseph Hsinting Lin |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 1600 Providence Dr, Waco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679000681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | BP10059857 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Southwest Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Hospital Medicine Physicians Llc | 9830510023 | 110 |
News Archive
Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation.
Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.
Daiichi Sankyo Company, Limited and ArQule, Inc. today announced that the first patient has been enrolled in the pivotal Phase 3 METIV-HCC (MET-high patients with tivantinib in HCC) trial of tivantinib (ARQ 197).
Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."
The JDRF today said it is encouraged that the Food and Drug Administration (FDA) has issued a draft guidance which appears to lay a foundation for accelerating the development and availability of artificial pancreas technology (AP) that will improve the lives of millions of Americans living with type 1 diabetes.
› Verified 5 days ago
| Entity Name | Midwest Hospitalist Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376011478 PECOS PAC ID: 9133465354 Enrollment ID: O20190109001451 |
News Archive
Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation.
Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.
Daiichi Sankyo Company, Limited and ArQule, Inc. today announced that the first patient has been enrolled in the pivotal Phase 3 METIV-HCC (MET-high patients with tivantinib in HCC) trial of tivantinib (ARQ 197).
Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."
The JDRF today said it is encouraged that the Food and Drug Administration (FDA) has issued a draft guidance which appears to lay a foundation for accelerating the development and availability of artificial pancreas technology (AP) that will improve the lives of millions of Americans living with type 1 diabetes.
› Verified 5 days ago
| Entity Name | Oklahoma Hospital Medicine Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871113761 PECOS PAC ID: 9830510023 Enrollment ID: O20200526000785 |
News Archive
Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation.
Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.
Daiichi Sankyo Company, Limited and ArQule, Inc. today announced that the first patient has been enrolled in the pivotal Phase 3 METIV-HCC (MET-high patients with tivantinib in HCC) trial of tivantinib (ARQ 197).
Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."
The JDRF today said it is encouraged that the Food and Drug Administration (FDA) has issued a draft guidance which appears to lay a foundation for accelerating the development and availability of artificial pancreas technology (AP) that will improve the lives of millions of Americans living with type 1 diabetes.
› Verified 5 days ago
| Entity Name | Oklahoma Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417577305 PECOS PAC ID: 5597186940 Enrollment ID: O20200610003448 |
News Archive
Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation.
Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.
Daiichi Sankyo Company, Limited and ArQule, Inc. today announced that the first patient has been enrolled in the pivotal Phase 3 METIV-HCC (MET-high patients with tivantinib in HCC) trial of tivantinib (ARQ 197).
Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."
The JDRF today said it is encouraged that the Food and Drug Administration (FDA) has issued a draft guidance which appears to lay a foundation for accelerating the development and availability of artificial pancreas technology (AP) that will improve the lives of millions of Americans living with type 1 diabetes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Hsinting Lin, DO 1600 Providence Dr, Waco, TX 76707-2261 Ph: (254) 313-4200 | Joseph Hsinting Lin, DO 1600 Providence Dr, Waco, TX 76707-2261 Ph: (254) 313-4200 |
News Archive
Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation.
Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.
Daiichi Sankyo Company, Limited and ArQule, Inc. today announced that the first patient has been enrolled in the pivotal Phase 3 METIV-HCC (MET-high patients with tivantinib in HCC) trial of tivantinib (ARQ 197).
Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."
The JDRF today said it is encouraged that the Food and Drug Administration (FDA) has issued a draft guidance which appears to lay a foundation for accelerating the development and availability of artificial pancreas technology (AP) that will improve the lives of millions of Americans living with type 1 diabetes.
› Verified 5 days ago
Allison L Hulme, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-750-8200 Fax: 254-750-8326 | |
Timothy Martindale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7104 New Sanger Rd, Waco, TX 76712 Phone: 254-741-1113 Fax: 254-741-1342 | |
Dr. Brian Douglas Bull, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 North Loop 340, Waco, TX 76705 Phone: 254-202-7500 Fax: 254-202-7599 | |
Dr. Matthew R Porter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W. State Hwy 6, Waco, TX 76712 Phone: 254-313-6700 Fax: 254-313-4531 | |
Lianda Mirella Martinez, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Franklin Ave, Suite B-c, Waco, TX 76701 Phone: 254-537-6590 Fax: 254-537-6599 | |
Dr. Aman A Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 | |
Dr. Rita L Haws, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200 Fax: 254-313-4549 |